Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Pediatric MRI Sedation
NCT01152021Phase 3Terminated
- Sponsor
- Boston Children's Hospital
- Start
- Aug 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Number of Adverse Events During the Sedation and Recovery Period at 24 hours. Started Aug 2011; status: terminated.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT01152021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152021.